Early syphilis, symptomatic
ICD-10 A52.0 is a billable code used to indicate a diagnosis of early syphilis, symptomatic.
Early syphilis, symptomatic, refers to the initial stage of syphilis infection characterized by the presence of symptoms such as primary chancre, secondary lesions, or systemic manifestations. This stage typically occurs within the first year of infection and is marked by the appearance of a painless ulcer (chancre) at the site of infection, often accompanied by lymphadenopathy. Secondary syphilis may present with a rash, mucous membrane lesions (such as mucous membrane pemphigoid), and flu-like symptoms. Early diagnosis and treatment are crucial to prevent progression to later stages of syphilis, which can lead to severe complications affecting multiple organ systems. The diagnosis is confirmed through serological testing, including non-treponemal tests (e.g., RPR, VDRL) and treponemal tests (e.g., FTA-ABS). Treatment typically involves the administration of benzathine penicillin G, with follow-up serological testing to ensure treatment efficacy.
Detailed clinical notes on symptoms, test results, and treatment plans.
Patients presenting with genital ulcers, rashes, or systemic symptoms.
Ensure all serological tests are documented and interpreted correctly.
Comprehensive patient history, including sexual history and risk factors.
Routine screenings in high-risk populations and symptomatic patients.
Documenting patient education on STI prevention and follow-up care.
Used when testing for syphilis in symptomatic patients.
Document the reason for testing and the results.
Infectious disease specialists should ensure comprehensive testing protocols are followed.
Common symptoms include a painless ulcer (chancre), swollen lymph nodes, and systemic symptoms such as fever and rash.
Diagnosis is made through clinical evaluation and serological testing, including both non-treponemal and treponemal tests.
The standard treatment is benzathine penicillin G, administered intramuscularly, with follow-up serological testing to confirm treatment success.
